CADASIL
Clinical trials for CADASIL explained in plain language.
Never miss a new study
Get alerted when new CADASIL trials appear
Sign up with your email to follow new studies for CADASIL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a palm extract help fight a rare genetic brain disease?
Disease control CompletedThis study tested a supplement called HOV-12020 (made from palm tocotrienols) in 50 adults aged 45-75 with CADASIL, a rare genetic disease that damages small blood vessels in the brain, leading to strokes and memory loss. The goal was to see if the supplement could reduce worseni…
Matched conditions: CADASIL
Phase: PHASE2 • Sponsor: Hovid Berhad • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
Gene sequencing breakthrough offers faster diagnosis for rare brain diseases
Diagnosis CompletedThis study looked at whether whole genome sequencing (a complete read of a person's DNA) can help diagnose leukodystrophies, a group of rare brain disorders affecting white matter, more effectively than standard methods. Researchers enrolled 236 children under 18 with abnormal br…
Matched conditions: CADASIL
Sponsor: Children's Hospital of Philadelphia • Aim: Diagnosis
Last updated Jun 15, 2026 19:07 UTC
-
Brain scans reveal hidden clues in rare stroke disorder
Knowledge-focused CompletedThis study looked at how blood flow and brain activity are linked in people with CADASIL, a rare genetic disease that causes small strokes. Researchers used MRI and EEG scans to measure these connections in 60 adults. The goal was to better understand the disease, not to test a n…
Matched conditions: CADASIL
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:07 UTC